PORTLAND, Oregon, April 26, 2016 /PRNewswire/ --
A new report published by Allied Market Research titled, "Pharmaceutical Excipients Market" projects that the world pharmaceuticals excipients market would reach $6.4 billion by 2020 at a CAGR of 7.6% during 2015 and 2020. Organic chemicals would continue to be the highest revenue-generating segment during the forecast period. North America and Europe will continue to be the lead revenue generating economies through 2020. These regions collectively accounted for about three-fourth of share in the global pharmaceutical excipients market in 2015.
(Logo: http://photos.prnewswire.com/prnh/20140911/647229 )
To know more about the pharmaceutical excipients market report, visit the website at https://www.alliedmarketresearch.com/pharmaceutical-excipients-market
Factors that drive the global pharmaceutical excipients market are rising demand for pharmaceutical drugs, increasing popularity of functional excipients, drug pipeline, development of novel excipients, and increasing generic drugs market caused by expiration of various bestseller drugs patents. Factors that are likely to impede the market growth include, supply chain issues, high market fragmentation, and implementation of stringent regulations.
Binders segment generated highest revenue in 2015 and is anticipated to maintain this trend throughout the forecast period. This is attributed to the higher use of binders in pharmaceutical drugs as compared to fillers and diluents. However, fillers and diluents led this segment in terms of volume (units) in 2015 and accounted for about one fourth of the overall market. Economical cost and high popularity of fillers and diluents across pharmaceutical and excipient industries were the key factors responsible for the dominance of filler and diluents segment.
Key findings of the study:
North America accounted for about one third of the overall market revenue in 2015 owing to the presence of large number of pharmaceutical companies. The pharmaceutical excipients market in the developing economies has lucrative growth opportunities due to the availability of inexpensive raw materials and economical workforce. The global pharmaceutical excipient manufacturers are relocating to the developing economies by adopting strategies such as, agreement & acquisition with the local players. Moreover, lack of stringent regulations for the production of excipients also supports its growth in the developing economies. The key companies included in the report are Ashland, Inc., BASF SE, Associated British Foods Plc, Akzo Nobel N.V., The Dow Chemical Company, Evonik, Merck, J.M. Huber Corporation, Covidien Plc, and Archer Daniels Midland.
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
Deep Joshi
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Int'l: +1-503-505-6949
Toll Free: +1-800-792-5285 (U.S. & Canada)
LinkedIn: https://www.linkedin.com/company/allied-market-research
Web: http://www.alliedmarketresearch.com
E-mail: sales@alliedmarketresearch.com
Share this article